176 related articles for article (PubMed ID: 29925826)
1. Synthesis, Structure, Chemical Stability, and In Vitro Cytotoxic Properties of Novel Quinoline-3-Carbaldehyde Hydrazones Bearing a 1,2,4-Triazole or Benzotriazole Moiety.
Korcz M; Sączewski F; Bednarski PJ; Kornicka A
Molecules; 2018 Jun; 23(6):. PubMed ID: 29925826
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-naproxen.
Han MI; Bekçi H; Uba AI; Yıldırım Y; Karasulu E; Cumaoğlu A; Karasulu HY; Yelekçi K; Yılmaz Ö; Küçükgüzel ŞG
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800365. PubMed ID: 31115928
[TBL] [Abstract][Full Text] [Related]
3. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
[TBL] [Abstract][Full Text] [Related]
5. New 3-(1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one-based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis-inducing agents.
Gaikwad NB; Bansode S; Biradar S; Ban M; Srinivas N; Godugu C; Yaddanapudi VM
Arch Pharm (Weinheim); 2021 Nov; 354(11):e2100074. PubMed ID: 34346099
[TBL] [Abstract][Full Text] [Related]
6. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Preliminary Cytotoxicity Studies of 1-[1-(4,5-Dihydrooxazol- 2-yl)-1H-indazol-3-yl]-3-phenylurea and 3-phenylthiourea Derivatives.
Kornicka A; Saczewski F; Bednarski PJ; Korcz M; Szumlas P; Romejko E; Sakowicz A; Sitek L; Wojciechowska M
Med Chem; 2017; 13(7):616-624. PubMed ID: 28266278
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety.
Bingul M; Tan O; Gardner CR; Sutton SK; Arndt GM; Marshall GM; Cheung BB; Kumar N; Black DS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27428941
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Antiproliferative Evaluation of Novel Hybrids of Dehydroabietic Acid Bearing 1,2,3-Triazole Moiety.
Li FY; Huang L; Li Q; Wang X; Ma XL; Jiang CN; Zhou XQ; Duan WG; Lei FH
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752282
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumoral evaluation of 7-chloro-4-quinolinylhydrazones derivatives.
Montenegro RC; Lotufo LV; de Moraes MO; Pessoa Cdo Ó; Rodrigues FA; Bispo Mde L; Cardoso LN; Kaiser CR; de Souza MV
Med Chem; 2011 Nov; 7(6):599-604. PubMed ID: 22316343
[TBL] [Abstract][Full Text] [Related]
11. 1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studies.
Anichina K; Argirova M; Tzoneva R; Uzunova V; Mavrova A; Vuchev D; Popova-Daskalova G; Fratev F; Guncheva M; Yancheva D
Chem Biol Interact; 2021 Aug; 345():109540. PubMed ID: 34139148
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel 2-alkyl triazole-3-alkyl substituted quinoline derivatives and their cytotoxic activity.
Sambasiva Rao P; Kurumurthy C; Veeraswamy B; Santhosh Kumar G; Shanthan Rao P; Pamanji R; Venkateswara Rao J; Narsaiah B
Bioorg Med Chem Lett; 2013 Mar; 23(5):1225-7. PubMed ID: 23352638
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors.
Liu M; Hou Y; Yin W; Zhou S; Qian P; Guo Z; Xu L; Zhao Y
Eur J Med Chem; 2016 Aug; 119():96-108. PubMed ID: 27155466
[TBL] [Abstract][Full Text] [Related]
14. Novel 1,2,3-Triazole-Containing Quinoline-Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking.
Krstulović L; Mišković Špoljarić K; Rastija V; Filipović N; Bajić M; Glavaš-Obrovac L
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836794
[TBL] [Abstract][Full Text] [Related]
15. Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 1: Triazoles, triazolopyrimidines, triazinoindoles, quinoline hydrazones and arylpiperazines.
Llona-Minguez S; Häggblad M; Martens U; Throup A; Loseva O; Jemth AS; Lundgren B; Scobie M; Helleday T
Bioorg Med Chem Lett; 2017 Aug; 27(16):3897-3904. PubMed ID: 28687206
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives.
Othman DIA; Selim KB; El-Sayed MA; Tantawy AS; Amen Y; Shimizu K; Okauchi T; Kitamura M
Bioorg Med Chem; 2019 Oct; 27(19):115026. PubMed ID: 31416740
[TBL] [Abstract][Full Text] [Related]
17. Anti-breast cancer activity of some novel quinoline derivatives.
Ghorab MM; Alsaid MS
Acta Pharm; 2015 Sep; 65(3):271-83. PubMed ID: 26431105
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics.
Easmon J; Pürstinger G; Thies KS; Heinisch G; Hofmann J
J Med Chem; 2006 Oct; 49(21):6343-50. PubMed ID: 17034140
[TBL] [Abstract][Full Text] [Related]
19. Design of new hybrid template by linking quinoline, triazole and dihydroquinoline pharmacophoric groups: A greener approach to novel polyazaheterocycles as cytotoxic agents.
Praveena KS; Shivaji Ramarao EV; Murthy NY; Akkenapally S; Kumar CG; Kapavarapu R; Pal S
Bioorg Med Chem Lett; 2015 Mar; 25(5):1057-63. PubMed ID: 25655719
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Cytotoxicity of Novel 2,4,6-Trisubstituted 1,3,5- triazines Bearing Aryl Hydrazone Moiety as Potent Antitumor Agent.
Wang L; Zhao S; Bao G; Zhang Y; Xi S; Zhou G; Zhai X; Gong P
Med Chem; 2016; 12(7):621-630. PubMed ID: 26732116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
